Clinical features of nonalcoholic steatohepatitis in Japan : evidence from the literature

スポンサーリンク

概要

論文の詳細を見る
2006-08-01

著者

関連論文

Decreased Lipoprotein Lipase in Obstructive Sleep Apnea Syndrome
Comparison of the effects of omeprazole and famotidine in treatment of upper abdominal symptoms in patients with reflux esophagitis
In vivo imaging of hepatic fatty acid metabolism in patients with nonalcoholic steatohepatitis using semiquantative ^I-BMIPP liver scan
CYP17 polymorphism and tamoxifen-induced hepatic steatosis
Evaluation of transcatheter arterial embolization therapy on hepatocellular carcinomas using contrast-enhanced harmonic power Doppler sonography : comparison with CT, power Doppler sonography, and dynamic MRI
Effects of nitric oxide on the redox status of liver microsomes-electron spin resonance monitoring using nitroxide probes
Activation of B-Myb by E2F1 in hepatocellular carcinoma
Vascularization in tissue remodeling after rat hepatic necrosis induced by dimethylnitrosamine
Aromatase-deficient (ArKO) mice are retrieved from severe hepatic steatosis by peroxisome proliferator administration
Visceral fat accumulation and insulin resistance are important factors in nonalcoholic fatty liver disease
Hepatic senescence marker protein-30 is involved in the progression of nonalcoholic fatty liver disease
Tamoxifen-induced nonalcoholic steatohepatitis in breast cancer patients treated with adjuvant tamoxifen
Clinical features of nonalcoholic steatohepatitis in Japan : evidence from the literature
Age-related fat deposition in multifidus muscle could be a marker for nonalcoholic fatty liver disease
A pilot trial of body weight reduction for nonalcoholic fatty liver disease with a home-based lifestyle modification intervention delivered in collaboration with interdisciplinary medical staff
Fibrate for treatment of primary biliary cirrhosis
Similar anti-mitochondrial antibody reactivity profiles in familial primary biliary cirrhosis
Bezafibrate may have a beneficial effect in pre-cirrhotic primary biliary cirrhosis
Primary biliary cirrhosis associated with benign monoclonal gammopathy
Nonalcoholic steatohepatitis in Asia-Oceania
Can an increase of body mass index by 1kg/m^2 be a risk for obesity-related diseases?
The pathological role of visceral fat accumulation in steatosis, inflammation, and progression of nonalcoholic fatty liver disease
Efficacy of long-term ezetimibe therapy in patients with nonalcoholic fatty liver disease
A simple clinical scoring system using ferritin, fasting insulin, and type IV collagen 7S for predicting steatohepatitis in nonalcoholic fatty liver disease
Effects of obstructive sleep apnea syndrome on hepatic steatosis and nonalcoholic steatohepatitis
Universal vaccination and thereafter
Platelet count for predicting fibrosis in nonalcoholic fatty liver disease
Prevalence and associated metabolic factors of nonalcoholic fatty liver disease in the general population from 2009 to 2010 in Japan : a multicenter large retrospective study
Serum Dehydroepiandrosterone Sulphate Levels in Patients with Non-Alcoholic Fatty Liver Disease
A Case of Mediastinal Pancreatic Pseudocyst Successfully Treated with Somatostatin Analogue
Clinical and pathological progression of non-alcoholic steatohepatitis to hepatocellular carcinoma
Angiotensinogen gene haplotype is associated with the prevalence of Japanese non-alcoholic steatohepatitis
Usefulness of Technetium-99 m-2-methoxy-isobutyl-isonitrile liver scintigraphy for evaluating disease activity of non-alcoholic fatty liver disease
noninvasive scoring systems in patients with nonalcoholic fatty liver disease with normal alanine aminotransferase levels

もっと見る

スポンサーリンク